Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The Spanish Government authorized the purchase of ten units of proton therapy equipment for the National Health System

On July 5, 2022, it was announced by the Ministry of Health that the Council of Ministers authorized the tender for the purchase of ten units of equipment for the treatment with proton therapy and associated electromedical equipment for an estimated value of €271 million (VAT included). The cost of the equipment will be financed by the Amancio Ortega Foundation.

This equipment is intended for public hospitals of the National Health System (SNS) in seven Autonomous Communities within the Proton therapy Implementation Plan for the treatment of tumors, especially in pediatric patients. Proton therapy equipment will be provided at the rates of:

  • One unit for the Basque Country, Galicia, Valencian Community, and the Canary Islands;
  • Two units for the Community of Madrid, Andalusia, and Catalonia.

With this agreement, the Proton therapy Implementation Plan of the SNS is distributed in four annuities: €28 million in 2022; €24.3 million in 2023; €121.5 million in 2024; and €97.2 million in 2025.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.